Covaxin vaccinated people might not be able to travel abroad soon:
People, who have been vaccinated with both the doses of Covaxin, India’s indigenous vaccine developed by Bharat Biotech, would not ...
Tag: Serum Institute of India
Vaccine Shortage in India: Global Exporter or Global Importer?
THD NewsDesk, New Delhi: An expert panel of 22-member highlighted that India’s current production capacity is insufficient to meet the ...
Serum Institute of India writes to PMO recommending reforms in drug regulatory system
THD NewsDesk, New Delhi: Serum Institute of India (SII); the world's largest vaccine manufacturer has written to the Prime Minister's ...
Covid vaccine beneficiaries may not have the option of choosing between Covaxin and Covishield
Both Covishield and Covaxin are being locally manufactured at SII and Bharat Biotech, respectively. Drug regulators and health secretary have ...
Will India have the COVID-19 vaccine soon enough?
THD NewsDesk, New Delhi: The United Kingdom has become the leading nation to approve Covid-19 vaccine. However, India remains to wait ...
SII files Rs 100 crore defamation suit against vaccine trial volunteer who sued it
SII has filed a defamation suit against a Chennai-based volunteer who claimed to suffer from neurological side-effects after taking the ...
Narendra Modi to visit the Serum Institute of India
PM Narendra Modi to visit Serum Insititute of India, Pune on Saturday He will review the mechanism of Covid-19 vaccine ...
SII CEO Adar Poonawalla says Oxford’s Covid vaccine candidate would be available by April 2021
SII CEO said the Oxford vaccine candidate would be made available for the public by April next year Priority would ...
Oxford University commences Human Trials of COVID-19 vaccines
THDNewsDesk, London : A new COVID-19 vaccine emanated from The University of Oxford has begun its experimentation. The human trials ...
Will Public Health be compromised to win the race of vaccine discovery?
THD NewsDesk, New Delhi: The Serum Institute of India is set to run Oxford University's Covishield Vaccine phase 3 trials ...
